BioCentury | Oct 29, 2020
Product Development
Flagship’s Senda builds on Kintai’s microbe-mimicking pipeline with plant and bacteria-based delivery modalities
...March, Flagship’s Repertoire Immune Medicines Inc. combined antigen-TCR matching company Cogen Therapeutics Inc....